metformin has been researched along with Influenza, Human in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz, A | 1 |
| Romero, M | 1 |
| Vazquez, T | 1 |
| Lechner, S | 1 |
| Blomberg, BB | 1 |
| Frasca, D | 1 |
1 other study available for metformin and Influenza, Human
| Article | Year |
|---|---|
Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes.
Topics: Antibodies, Viral; B-Lymphocytes; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Im | 2017 |